# Lenalidomide Maintenance Therapy Post Autologous Transplant for Hodgkins Lymphoma

> **NCT01207921** · PHASE1 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 28 (actual)

## Conditions studied

- Hodgkin Disease

## Interventions

- **DRUG:** Lenalidomide

## Key facts

- **NCT ID:** NCT01207921
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04-28
- **Primary completion:** 2016-09-19
- **Final completion:** 2021-03-05
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2021-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01207921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01207921, "Lenalidomide Maintenance Therapy Post Autologous Transplant for Hodgkins Lymphoma". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01207921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*